This peptide, which he named exendin-4 , was approximately 53% identical in amino acid sequence to human GLP-1, but with one critical difference: while human GLP-1 is degraded by an enzyme called DPP-4 within minutes of being released, exendin-4 was resistant to that breakdown
The underlying scientific question - whether oral compounded peptide medications have sufficient bioavailability to produce clinically meaningful GLP-1 effects - is an appropriate question to ask your assigned provider directly before starting any compounded oral GLP-1 program, including FeelGood's Compounded Tablets tier
Therefore it did not present the risk of making glucose levels go too high or too low, which was a common problem with other diabetic treatments (Amylin)
Prepare ahead: Keep your medication and supplies in one designated, easy-to-access spot
Diabetes indications are often treated differently from obesity indications
However, some effects like decreased appetite may persist as part of the medications intended action